Products & Service

Our Products

Technetium Tc99m generator

DS GEN is a state-of-the-art dry-type Mo-99/Tc-99m generator, designed to reliably produce high-purity, sterile, pyogen-free, isotonic sodium pertechnetate (99mTc) injection suitable for intravenous use or for radiolabelling of pharmaceutical kits.

Iodine -131 solutions and capsules

SDS Iodine products contain Iodine-131 in either oral solution or capsule form, of hard gelatin/ cellulose capsules, packaged in Type I glass vials , enclosed within shielding containers for radiation protection.

FDG & F18 based products

SDS F-18 (FDG) is primarily used in positron emission tomography (PET) imaging across various medical fields such as oncology, Neurology, & Cardiology. Fluorodeoxyglucose (18F-FDG) is the most widely used PET radiotracer for tumour imaging in oncology

Lu-177 labelled products

SDS LU-DOTA is a ready-to-use radiopharmaceutical formulation of Lutetium-177 DOTATATE, designed for targeted peptide receptor radionuclide therapy (PRRT) in patients with somatostatin receptor-positive neuroendocrine tumours (NETs).

Technetium Cold kits

Each kit is supplied in a Type I glass vial, sealed under nitrogen atmosphere and packed in a sterile, tamper-evident carton with detailed labelling including product name, batch number, manufacturing date, and expiry date.

Calibration services

As per AERB recommendations, Dose Calibrators must be calibrated once every two years from the date they are placed in service. SDS offers Dose Calibrator recalibration services for all kinds of brands. Our Calibration Facility is an accredited NABL laboratory

Peptides

Precursor for radiolabelling with Lutetium-177 (¹⁷⁷Lu), Gallium-68 (⁶⁸Ga), or Yttrium-90 (⁹⁰Y) to prepare radiolabelled DOTA-[Tyr³]-Octreotate for use in targeted radionuclide therapy (PRRT) and diagnostic imaging of somatostatin-receptor-positive neuroendocrine tumours

Contract manufacturing & Clinical research

We also offer contract manufacturing services and Clinical services as per the requirement.

Actinium-225

Actinium-225 (Ac-225) is emerging as one of the most promising radionuclides in Targeted Alpha Therapy (TAT). With its powerful alpha-emitting properties and suitability for radiopharmaceutical applications